A. Mikami

发表

Assessments of plasma concentrations, pathology symptoms, and cognition following paliperidone treatment in schizophrenic patients previously treated with risperidone.

H. Matsumoto, Y. Inoue, Hidenobu Suzuki, 2017, Asian journal of psychiatry.

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial (Preprint)

W. Sugiura, N. Ohmagari, H. Sugiyama, 2020 .

Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals

H. Mitsuya, W. Sugiura, S. Oka, 2021 .

[Impact of the change in criteria for hospital discharge of patients with tuberculosis based on the duration of hospitalization].

N. Ishizuka, E. Toyota, N. Keicho, 2005, Kekkaku : [Tuberculosis].

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)

M. Satake, Y. Takamatsu, S. Kutsuna, 2022, Life.

Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan.

W. Sugiura, N. Ohmagari, N. Kokudo, 2021, Global health & medicine.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Michael R. Wierzbicki, Tom M. Conrad, Cameron R. Wolfe, 2021, The Lancet Respiratory Medicine.

Efficacy and Safety of Direct Hemoperfusion using Polymyxin B-Immobilized Polystyrene Column (PMX-DHP) for COVID-19 Patients: Exploratory Study Protocol.

H. Sugiyama, Y. Uemura, A. Azuma, 2022, JMIR research protocols.

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.

N. Kitamura, T. Hirai, Y. Inoue, 2019, The New England journal of medicine.

of patients with idiopathic pulmonary alveolar proteinosis granulocyte-macrophage colony-stimulating factor activity in the lungs High-affinity autoantibodies specifically eliminate

Y. Eishi, B. Trapnell, Yoshitsugu Yamada, 2013 .

High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

Y. Eishi, N. Keicho, B. Trapnell, 2003, Blood.

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Catharine I Paules, R. Hyzy, M. Proschan, 2022, The Lancet Respiratory Medicine.

Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis.

K. Nagai, N. Kitamura, T. Hirai, 2016, Annals of the American Thoracic Society.

Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan.

W. Sugiura, N. Ohmagari, A. Mikami, 2020, Global health & medicine.

Relationship between the plasma concentration of paliperidone and the clinical and drug‐induced extrapyramidal symptoms in elderly patients with schizophrenia

H. Matsumoto, Y. Inoue, K. Mikami, 2014, Human psychopharmacology.

The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: A preliminary open-label trial

H. Matsumoto, Y. Inoue, K. Mikami, 2014, International journal of psychiatry in clinical practice.

The RACCO Trial to Assess the Efficacy and Safety of Inhaled Ciclesonide for Asymptomatic and Mild Patients with Covid-19: A Study Protocol for a Multi-center, Open- labeled, Randomized Controlled Trial.

W. Sugiura, N. Ohmagari, H. Sugiyama, 2020, JMIR research protocols.

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan

W. Sugiura, H. Ohtsu, N. Ohmagari, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA)

Y. Takamatsu, J. Takeuchi, Y. Uemura, 2022, Life.

Study of the efficacy and safety of switching from risperidone to paliperidone in elderly patients with schizophrenia

H. Matsumoto, Y. Inoue, K. Mikami, 2013, Psychiatry and clinical neurosciences.

Mechanisms for the α-Adrenoceptor-Mediated Positive Inotropy in Mouse Ventricular Myocardium: Enhancing Effect of Action Potential Prolongation

Iyuki Namekata, Hikaru Tanaka, Shogo Hamaguchi, 2023, International journal of molecular sciences.

Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

H. Mitsuya, W. Sugiura, S. Oka, 2021, Scientific Reports.

Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals

S. Oka, Y. Takamatsu, Y. Uemura, 2021, medRxiv.

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan

Y. Takamatsu, N. Ohmagari, J. Takeuchi, 2023, Human vaccines & immunotherapeutics.

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

Akiko Kimura, M. Satake, Y. Takamatsu, 2023, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial

W. Sugiura, N. Ohmagari, H. Sugiyama, 2020, JMIR Research Protocols.

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

S. Kutsuna, N. Ohmagari, I. Hamaguchi, 2023 .

Validation of a new serum granulocyte–macrophage colony-stimulating factor autoantibody testing kit

N. Kitamura, T. Hirai, S. Konno, 2020, ERJ Open Research.

Reduced insomnia following short-term administration of suvorexant during aripiprazole once-monthly treatment in a patient with schizophrenia.

H. Matsumoto, Y. Inoue, K. Mikami, 2017, Asian journal of psychiatry.